Last edition
News about "Staphylococcus Aureus Bacteriophage treatment"
Armata Pharmaceuticals Gets 2 US Patent Issuances
Armata Pharmaceuticals has secured 2 US patents for AP-SA02 and AP-PA02, extending IP protection for the clinical candidates until at least 2041.
Staphylococcus Aureus Bacteriophage Treatment | 08/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members